Eevia Health Plc - Notification of management's transactions
Eevia Health Plc has received the following notification pursuant to Article 19 of the Market Abuse Regulation:
____________________________________________
Person subject to the notification requirement
Name: Nurmi-Aro, Kim
Position: Chief Financial Officer
Issuer: Eevia Health Plc
LEI: 743700NO7D0UA8J1MQ31
Notification type: INITIAL NOTIFICATION
Reference number: 743700NO7D0UA8J1MQ31_20210621133215_4
____________________________________________
Transaction date: 2021-06-17
Venue: SPOTLIGHT (XSAT)
Instrument type: SHARE
ISIN: FI4000496658
Nature of the transaction: SUBSCRIPTION
Transaction details
(1): Volume: 13,200 Unit price: 0.745 EUR
Aggregated transactions
(1): Volume: 13,200 Volume weighted average price: 0.745 EUR
For more information, please contact:
Kim Nurmi-Aro, CFO
Tel.: +358 504 44 0717
About Eevia
Eevia Health Plc, founded in March 2017, is a small, but fast-growing Finnish manufacturer of 100% organically certified plant extracts. The Company addresses significant health problems with bioactive compounds extracted from plant material from the pristine Finnish forests near the Arctic Circle. The extracts, which have scientifically documented health benefits, are sold B2B as ingredients to dietary supplements and food brands globally.
To learn more, please visit www.eeviahealth.com or follow Eevia Health on LinkedIn @EeviaHealth.